Core Viewpoint - The company, Yimai Sunshine, remains optimistic about its long-term development prospects and is actively responding to investor concerns through share buybacks and management purchases, indicating strong confidence in its future [1][2] Group 1: Company Operations and Strategy - Yimai Sunshine confirms that its operations are normal and stable, with core business progress proceeding smoothly, adhering to its established strategy in medical data and artificial intelligence [1] - The management believes that recent market fluctuations are disconnected from the company's fundamentals, emphasizing that short-term volatility does not alter the long-term value [1] Group 2: Share Buyback and Management Purchase - The company plans to repurchase H-shares in the open market, with a total amount not exceeding 200 million HKD, based on recent achievements in regional medical imaging sharing centers and data services [1] - The buyback plan aims to stabilize the stock price and enhance shareholder returns, reflecting the company's confidence in its future development [1] - Chairman and CEO Chen Chaoyang purchased 59,500 shares at an average price of 10.10 HKD per share, totaling 600,950 HKD, increasing his ownership stake to 14.48% [2]
一脉阳光积极回应投资者关切:长期看好公司发展前景 回购+增持彰显坚定信心
Ge Long Hui·2025-12-09 01:32